A. Gharbharan

发表

A comparative study of software programmes for cross‐sectional skeletal muscle and adipose tissue measurements on abdominal computed tomography scans of rectal cancer patients

Wiro J. Niessen, Marcel Koek, Sten P. Willemsen, 2016, Journal of cachexia, sarcopenia and muscle.

Prospective individual patient data meta-analysis of two randomized trials on convalescent plasma for COVID-19 outpatients

Q. Bassat, B. Clotet, A. Troxel, 2022, Nature Communications.

Effects of Treatment of Coronavirus Disease 2019 With Convalescent Plasma in 25 B-Cell–Depleted Patients

C. E. van der Schoot, M. van der Klift, C. Geurtsvankessel, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Outpatient convalescent plasma therapy for high-risk patients with early COVID-19: a randomized placebo-controlled trial

M. Koopmans, E. V. van Zwet, J. Miedema, 2022, Clinical Microbiology and Infection.

Effects of potent neutralizing antibodies from convalescent plasma in patients hospitalized for severe SARS-CoV-2 infection

A. Dofferhof, M. Koopmans, A. Koster, 2020, Nature Communications.

Convalescent Plasma for COVID-19. A randomized clinical trial

M. M. van der Eerden, M. Koopmans, A. Koster, 2020, medRxiv.

The Association of Computed Tomography-Assessed Body Composition with Mortality in Patients with Necrotizing Pancreatitis

C. V. van Eijck, M. Besselink, J. van Grinsven, 2017, Journal of Gastrointestinal Surgery.

Interferon-α2 Auto-antibodies in Convalescent Plasma Therapy for COVID-19

M. Koopmans, H. Endeman, B. Haagmans, 2021, Journal of clinical immunology.

Association of Convalescent Plasma Treatment With Clinical Status in Patients Hospitalized With COVID-19

L. Pirofski, E. Antman, T. Tarpey, 2022, JAMA network open.

Comparison of SIRS criteria and qSOFA score for identifying culture-positive sepsis in the emergency department: a prospective cross-sectional multicentre study

J. Dieleman, A. Gharbharan, H. Haak, 2021, BMJ Open.

COVID-19 Convalescent Plasma Outpatient Therapy to Prevent Outpatient Hospitalization: A Meta-analysis of Individual Participant Data From Five Randomized Trials

C. Callaway, F. Polack, J. Zwaginga, 2022, medRxiv.

Coronavirus Disease 2019 Convalescent Plasma Outpatient Therapy to Prevent Outpatient Hospitalization: A Meta-Analysis of Individual Participant Data From 5 Randomized Trials

C. Callaway, F. Polack, J. Zwaginga, 2023, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

High incidence of sotrovimab resistance and viral persistence after treatment of immunocompromised patients infected with the SARS-CoV-2 Omicron variant

M. Koopmans, B. Rijnders, A. Gharbharan, 2022, medRxiv.

Convalescent plasma for outpatients with early COVID-19

Q. Bassat, B. Clotet, N. van Geloven, 2021, medRxiv.

Sotrovimab Resistance and Viral Persistence After Treatment of Immunocompromised Patients Infected With the Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant

A. Gharbharan, B. O. Munnink, Sammy Huygens, 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

High-titer convalescent plasma plus nirmatrelvir/ritonavir treatment for non-resolving COVID-19 in six immunocompromised patients

B. O. Oude Munnink, C. Geurtsvankessel, B. Rijnders, 2023, The Journal of antimicrobial chemotherapy.

Clinical and Virological Outcome of Monoclonal Antibody Therapies Across SARS-CoV-2 Variants in 245 Immunocompromised Patients: A Multicenter Prospective Cohort Study

H. Bax, B. O. Oude Munnink, C. Geurtsvankessel, 2024, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.